Twin Peaks Wealth Advisors, LLC Ionis Pharmaceuticals Inc Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 215 shares of IONS stock, worth $14,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215Holding current value
$14,822% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
414Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.15 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.11 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$865 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$712 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$541 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $9.79B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...